雷尼替丁对利多卡因处置无影响。
Lack of effect of ranitidine on the disposition of lignocaine.
作者信息
Feely J, Guy E
出版信息
Br J Clin Pharmacol. 1983 Mar;15(3):378-9. doi: 10.1111/j.1365-2125.1983.tb01514.x.
Abstract
Cimetidine has been shown to alter the disposition of lignocaine and other drugs that are highly extracted by the liver. In a placebo controlled study ranitidine (150 mg twice daily) did not alter the elimination half-life, systemic clearance or distribution of lignocaine (mg/kg) in six healthy subjects. The interaction with cimetidine appears to be unrelated to histamine H2-receptor antagonism.
摘要
已证明西咪替丁可改变利多卡因及其他经肝脏高度摄取的药物的处置过程。在一项安慰剂对照研究中，雷尼替丁（每日两次，每次150毫克）并未改变6名健康受试者体内利多卡因的消除半衰期、全身清除率或分布（毫克/千克）。与西咪替丁的相互作用似乎与组胺H2受体拮抗作用无关。
相似文献
1
Lack of effect of ranitidine on the disposition of lignocaine.雷尼替丁对利多卡因处置无影响。
Br J Clin Pharmacol. 1983 Mar;15(3):378-9. doi: 10.1111/j.1365-2125.1983.tb01514.x.
2
Effects of cimetidine and ranitidine on hepatic drug metabolism.西咪替丁和雷尼替丁对肝脏药物代谢的影响。
Clin Pharmacol Ther. 1982 Mar;31(3):297-300. doi: 10.1038/clpt.1982.36.
3
Lack of effect of ranitidine on warfarin action.雷尼替丁对华法林作用无影响。
Br J Clin Pharmacol. 1981 Dec;12(6):791-4. doi: 10.1111/j.1365-2125.1981.tb01308.x.
4
[Effect of histamine H2-receptor antagonists on the hepatic elimination of drugs].[组胺H2受体拮抗剂对药物肝脏清除的影响]
Klin Wochenschr. 1983 Jul 1;61(13):625-32. doi: 10.1007/BF01487578.
5
Cimetidine and ranitidine: comparison of effects on hepatic drug metabolism.西咪替丁和雷尼替丁：对肝脏药物代谢影响的比较。
Br Med J. 1980 Sep 20;281(6243):775-7. doi: 10.1136/bmj.281.6243.775.
6
Effects of histamine-2 receptor blockade on lidocaine kinetics.组胺-2受体阻断对利多卡因动力学的影响。
Clin Pharmacol Ther. 1985 May;37(5):544-8. doi: 10.1038/clpt.1985.86.
7
[Influence of ranitidine on antipyrine metabolism (author's transl)].雷尼替丁对安替比林代谢的影响（作者译）
Z Gastroenterol. 1980 Dec;18(12):601-4.
8
Effect of H2-receptor antagonists on steady-state extraction of indocyanine green and lidocaine by the perfused rat liver.H2受体拮抗剂对灌注大鼠肝脏中吲哚菁绿和利多卡因稳态摄取的影响。
J Lab Clin Med. 1986 Feb;107(2):112-7.
9
The effect of ranitidine on the disposition of lignocaine.雷尼替丁对利多卡因处置的影响。
Br J Clin Pharmacol. 1985 Aug;20(2):170-3. doi: 10.1111/j.1365-2125.1985.tb05053.x.
10
The effect of histamine-2 receptor antagonists on tocainide pharmacokinetics.组胺-2受体拮抗剂对妥卡尼药代动力学的影响。
J Clin Pharmacol. 1988 Jul;28(7):640-3. doi: 10.1002/j.1552-4604.1988.tb03188.x.
引用本文的文献
1
Drug interactions through binding to cytochrome p 450: the experience with h2-receptor blocking agents.通过与细胞色素 p450 结合的药物相互作用：H2 受体阻滞剂的经验。
Pharm Res. 1984 Mar;1(2):59-62. doi: 10.1023/A:1016347229923.
2
Adverse effects and drug interactions associated with local and regional anaesthesia.与局部和区域麻醉相关的不良反应及药物相互作用。
Drug Saf. 1998 Apr;18(4):221-50. doi: 10.2165/00002018-199818040-00001.
3
H2 receptor antagonists--cimetidine and ranitidine.H2受体拮抗剂——西咪替丁和雷尼替丁。
Br Med J (Clin Res Ed). 1983 Apr 16;286(6373):1283. doi: 10.1136/bmj.286.6373.1283.
4
H2 receptor antagonists: cimetidine and ranitidine.H2受体拮抗剂：西咪替丁和雷尼替丁。
Br Med J (Clin Res Ed). 1983 Apr 30;286(6375):1440. doi: 10.1136/bmj.286.6375.1440.
5
Interactions and non-interactions with ranitidine.与雷尼替丁的相互作用及非相互作用
Clin Pharmacokinet. 1984 Nov-Dec;9(6):493-510. doi: 10.2165/00003088-198409060-00002.
6
Dose and concentration dependent effect of ranitidine on procainamide disposition and renal clearance in man.雷尼替丁对人体内普鲁卡因胺处置和肾清除率的剂量及浓度依赖性效应。
Br J Clin Pharmacol. 1984 Aug;18(2):175-81. doi: 10.1111/j.1365-2125.1984.tb02450.x.
7
The effect of ranitidine on the disposition of lignocaine.雷尼替丁对利多卡因处置的影响。
Br J Clin Pharmacol. 1985 Aug;20(2):170-3. doi: 10.1111/j.1365-2125.1985.tb05053.x.
8
Effects of ranitidine on the disposition of metoprolol.雷尼替丁对美托洛尔处置的影响。
Br J Clin Pharmacol. 1985 Feb;19(2):219-24. doi: 10.1111/j.1365-2125.1985.tb02634.x.
9
Ranitidine versus cimetidine. A comparison of their potential to cause clinically important drug interactions.雷尼替丁与西咪替丁。二者引发具有临床重要性药物相互作用可能性的比较。
Clin Pharmacokinet. 1988 Jul;15(1):44-56. doi: 10.2165/00003088-198815010-00004.
10
The pharmacokinetics of lignocaine and beta-adrenoceptor antagonists in patients with acute myocardial infarction.利多卡因和β-肾上腺素受体拮抗剂在急性心肌梗死患者中的药代动力学。
Clin Pharmacokinet. 1987 Nov;13(5):293-316. doi: 10.2165/00003088-198713050-00002.
本文引用的文献
1
Reduction of liver blood flow and propranolol metabolism by cimetidine.西咪替丁对肝血流量及普萘洛尔代谢的影响
N Engl J Med. 1981 Mar 19;304(12):692-5. doi: 10.1056/NEJM198103193041202.
2
Lignocaine and indocyanine green kinetics in patients following myocardial infarction.心肌梗死后患者的利多卡因和吲哚菁绿动力学
Br J Clin Pharmacol. 1980 Oct;10(4):353-61. doi: 10.1111/j.1365-2125.1980.tb01771.x.
3
Increased toxicity and reduced clearance of lidocaine by cimetidine.西咪替丁增加利多卡因的毒性并降低其清除率。
Ann Intern Med. 1982 May;96(5):592-4. doi: 10.7326/0003-4819-96-5-592.
4
Lack of effect of ranitidine on warfarin action.雷尼替丁对华法林作用无影响。
Br J Clin Pharmacol. 1981 Dec;12(6):791-4. doi: 10.1111/j.1365-2125.1981.tb01308.x.
5
Gas chromatographic method for the quantitative determination of lidocaine and its metabolite monoethylglycinexylidide in plasma.血浆中利多卡因及其代谢物单乙基甘氨酰二甲苯胺定量测定的气相色谱法。
J Chromatogr. 1976 Jan 7;116(1):188-93. doi: 10.1016/s0021-9673(00)83718-8.
6
Cimetidine: interaction with oral anticoagulants in man.西咪替丁：与人体口服抗凝剂的相互作用。
Lancet. 1979 Aug 18;2(8138):317-9. doi: 10.1016/s0140-6736(79)90340-4.
7
Altered hepatic blood flow and drug disposition.肝脏血流和药物处置的改变。
Clin Pharmacokinet. 1976;1(2):135-55. doi: 10.2165/00003088-197601020-00005.
Zotero 插件